Insider Trading Alert - Ecolab And 4 Others Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Sept. 5, 2013, 166 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1.00 to $287,182,000.00.

Highlighted Stocks Traded by Insiders:

Ecolab (ECL) - FREE Research Report

Levin Jerry W who is Director at Ecolab sold 1,075 shares at $92.63 on Sept. 5, 2013. Following this transaction, the Director owned 28,577 shares meaning that the stake was reduced by 3.63% with the 1,075 share transaction.

The shares most recently traded at $93.23, up $0.60, or 0.64% since the insider transaction. Historical insider transactions for Ecolab go as follows:

  • 4-Week # shares bought: 2,000
  • 12-Week # shares bought: 2,000
  • 24-Week # shares bought: 7,935
  • 24-Week # shares sold: 15,837

The average volume for Ecolab has been 1.0 million shares per day over the past 30 days. Ecolab has a market cap of $28.2 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 29.51% year to date as of the close of trading on Thursday.

Ecolab Inc. develops and markets programs, products, and services for hospitality, foodservice, healthcare, industrial, and energy markets worldwide. It operates through four segments: Global Industrial, Global Institutional, Global Energy, and Other. The stock currently has a dividend yield of 0.98%. The company has a P/E ratio of 33.6. Currently there are 11 analysts that rate Ecolab a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ECL - FREE

TheStreet Quant Ratings rates Ecolab as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, compelling growth in net income, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Ecolab Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Ciena Corporation (CIEN) - FREE Research Report

Smith Gary B who is President, Ceo at Ciena Corporation sold 2,900 shares at $22.34 on Sept. 5, 2013. Following this transaction, the President, Ceo owned 297,712 shares meaning that the stake was reduced by 0.96% with the 2,900 share transaction.

Morin Philippe who is SVP, Global Field Organization at Ciena Corporation sold 4,000 shares at $22.35 on Sept. 5, 2013. Following this transaction, the SVP, Global Field Organization owned 201,009 shares meaning that the stake was reduced by 1.95% with the 4,000 share transaction.

The shares most recently traded at $24.16, up $1.81, or 7.49% since the insider transaction. Historical insider transactions for Ciena Corporation go as follows:

  • 4-Week # shares sold: 16,700
  • 12-Week # shares sold: 105,801
  • 24-Week # shares sold: 165,108

The average volume for Ciena Corporation has been 3.3 million shares per day over the past 30 days. Ciena Corporation has a market cap of $2.4 billion and is part of the technology sector and telecommunications industry. Shares are up 50.06% year to date as of the close of trading on Thursday.

Ciena Corporation provides communications networking equipment, software, and services that support the transport, switching, aggregation, and management of voice, video, and data traffic worldwide. Currently there are 12 analysts that rate Ciena Corporation a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CIEN - FREE

TheStreet Quant Ratings rates Ciena Corporation as a sell. Among the areas we feel are negative, one of the most important has been weak operating cash flow. Get the full Ciena Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Cubist Pharmaceuticals (CBST) - FREE Research Report

Tomsicek Michael John who is SVP & Chief Financial Officer at Cubist Pharmaceuticals sold 400 shares at $64.08 on Sept. 5, 2013. Following this transaction, the SVP & Chief Financial Officer owned 2,341 shares meaning that the stake was reduced by 14.59% with the 400 share transaction.

The shares most recently traded at $63.91, down $0.17, or 0.27% since the insider transaction.

The average volume for Cubist Pharmaceuticals has been 962,700 shares per day over the past 30 days. Cubist Pharmaceuticals has a market cap of $4.1 billion and is part of the health care sector and drugs industry. Shares are up 47.94% year to date as of the close of trading on Thursday.

Cubist Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of pharmaceutical products for various medical needs in the acute care environment in the United States. The company has a P/E ratio of 45.1. Currently there are 8 analysts that rate Cubist Pharmaceuticals a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CBST - FREE

TheStreet Quant Ratings rates Cubist Pharmaceuticals as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Cubist Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Markel Corporation (MKL) - FREE Research Report

Markel Anthony F who is Vice Chairman at Markel Corporation sold 57 shares at $516.70 on Sept. 5, 2013. Following this transaction, the Vice Chairman owned 3,528 shares meaning that the stake was reduced by 1.59% with the 57 share transaction.

The shares most recently traded at $517.40, up $0.70, or 0.14% since the insider transaction. Historical insider transactions for Markel Corporation go as follows:

  • 4-Week # shares sold: 300
  • 12-Week # shares sold: 300
  • 24-Week # shares sold: 300

The average volume for Markel Corporation has been 40,600 shares per day over the past 30 days. Markel Corporation has a market cap of $7.2 billion and is part of the financial sector and insurance industry. Shares are up 18.55% year to date as of the close of trading on Thursday.

Markel Corporation markets and underwrites specialty insurance products in the United States and internationally. It operates in three segments: Excess and Surplus Lines, Specialty Admitted, and London Insurance Market. The company has a P/E ratio of 23.2. Currently there are 2 analysts that rate Markel Corporation a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MKL - FREE

TheStreet Quant Ratings rates Markel Corporation as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, solid stock price performance, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Markel Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Hain Celestial Group (HAIN) - FREE Research Report

Icahn Carl C who is no longer subject to Sec. 16 at Hain Celestial Group sold 3.7 million shares at $78.68 on Sept. 5, 2013. Following this transaction, the no longer subject to Sec. 16 owned 3.6 million shares meaning that the stake was reduced by 50.41% with the 3.7 million share transaction.

The shares most recently traded at $79.84, up $1.16, or 1.45% since the insider transaction. Historical insider transactions for Hain Celestial Group go as follows:

  • 4-Week # shares sold: 4,834
  • 12-Week # shares sold: 4,834
  • 24-Week # shares sold: 4,834

The average volume for Hain Celestial Group has been 491,000 shares per day over the past 30 days. Hain Celestial Group has a market cap of $3.8 billion and is part of the services sector and wholesale industry. Shares are up 46.24% year to date as of the close of trading on Thursday.

The Hain Celestial Group, Inc., together with its subsidiaries, manufactures, markets, distributes, and sells natural and organic products. The company has a P/E ratio of 31.8. Currently there are 10 analysts that rate Hain Celestial Group a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HAIN - FREE

TheStreet Quant Ratings rates Hain Celestial Group as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Hain Celestial Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research
null